scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012665047 |
P356 | DOI | 10.1186/1742-2094-9-177 |
P932 | PMC publication ID | 3464795 |
P698 | PubMed publication ID | 22818222 |
P5875 | ResearchGate publication ID | 229434470 |
P50 | author | Jerel Adam Fields | Q91173557 |
Anuja Ghorpade | Q121461578 | ||
P2860 | cites work | A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family | Q24310416 |
Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut | Q24323994 | ||
CCAAT/enhancer-binding proteins: structure, function and regulation | Q24534323 | ||
Molecular dissection of reactive astrogliosis and glial scar formation | Q24646628 | ||
Astrocytes: biology and pathology | Q27490746 | ||
Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study | Q28579678 | ||
Astrocytes are active players in cerebral innate immunity | Q29620562 | ||
Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy | Q33316645 | ||
Immune and inflammatory responses in the CNS: modulation by astrocytes | Q33534014 | ||
Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions | Q33572041 | ||
Astrocyte-induced modulation of synaptic transmission | Q33776466 | ||
Inflammatory mediators and modulation of blood-brain barrier permeability | Q33851290 | ||
Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein | Q34148151 | ||
Pathways to neuronal injury and apoptosis in HIV-associated dementia. | Q34223078 | ||
Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. | Q34287122 | ||
IL-1-regulated responses in astrocytes: relevance to injury and recovery | Q34357276 | ||
Immune function of astrocytes | Q34398643 | ||
Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression | Q34607184 | ||
Biological role of the CCAAT/enhancer-binding protein family of transcription factors | Q34663643 | ||
Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes | Q34769788 | ||
Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders | Q35022812 | ||
CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. | Q35038078 | ||
Inhibition of lipopolysaccharide‐inducible nitric oxide synthase, TNF‐α and COX‐2 expression by sauchinone effects on I‐κBα phosphorylation, C/EBP and AP‐1 activation | Q35045262 | ||
Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes | Q36099522 | ||
Multiple forms of C/EBP beta bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat | Q36657531 | ||
Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription. | Q36959617 | ||
Blood-brain barrier: structural components and function under physiologic and pathologic conditions | Q37015412 | ||
Pathological roles of MAPK signaling pathways in human diseases | Q37676393 | ||
Kallikrein-kinin system mediated inflammation in Alzheimer's disease in vivo | Q37818425 | ||
The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts | Q38297445 | ||
Microarray analysis supports a role for ccaat/enhancer-binding protein-beta in brain injury | Q38345722 | ||
Regulation of complement component C3 in astrocytes by IL-1beta and morphine. | Q40017034 | ||
Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases | Q40300764 | ||
The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors | Q40773513 | ||
CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling | Q41039894 | ||
Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-kappaB and C/EBP isoforms | Q42466928 | ||
IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain | Q42573892 | ||
Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. | Q43560467 | ||
Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage | Q43706917 | ||
Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier | Q44182835 | ||
CCAAT/enhancer binding protein beta deficiency provides cerebral protection following excitotoxic injury | Q46664679 | ||
Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model | Q48186077 | ||
Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. | Q48381541 | ||
A transcriptional role for C/EBP beta in the neuronal response to axonal injury | Q48868508 | ||
Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism | Q49077300 | ||
Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. | Q52245350 | ||
Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes | Q61774073 | ||
Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response | Q67895445 | ||
P921 | main subject | astrocyte | Q502961 |
human astrocyte | Q67801129 | ||
P304 | page(s) | 177 | |
P577 | publication date | 2012-07-20 | |
P1433 | published in | Journal of Neuroinflammation | Q15716679 |
P1476 | title | C/EBPβ regulates multiple IL-1β-induced human astrocyte inflammatory genes | |
P478 | volume | 9 |
Q35844497 | An anti-inflammatory role for C/EBPδ in human brain pericytes |
Q42670542 | CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease |
Q38993294 | DNA microarray analysis of genes differentially expressed in adipocyte differentiation |
Q41412807 | Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes. |
Q28392199 | HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads |
Q50295671 | Modelling physiological and pathological conditions to study pericyte biology in brain function and dysfunction. |
Q37532357 | Neuregulin-1 attenuates mortality associated with experimental cerebral malaria |
Q59799020 | Profiling the proteomic inflammatory state of human astrocytes using DIA mass spectrometry |
Q24310121 | Stabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1β-stimulated C/EBP signaling pathway |
Q39033394 | The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms |
Q39029652 | Transcription factor C/EBP-β mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells |
Q91813239 | Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder |